Estrada for menopause: care for the chapter you are in
Your periods have stopped. The night sweats, disrupted sleep or discomfort may still be taking up space in your life. Whether you are considering hormone therapy for the first time or revisiting an earlier decision, your care should start with what you need now.
After menopause, an HRT decision depends on your symptoms, health history, age and time since menopause. Estrada is Soha's compounded estradiol-and-progesterone vaginal cream, intended for systemic hormone therapy, with OB/GYN evaluation and prescribing when appropriate. It is not the same as low-dose local vaginal estrogen and is not FDA-approved. Your assessment should compare suitable options, benefits and risks.
Menopause changes the context of your care
Natural menopause is identified after 12 consecutive months without a period when another cause does not explain it. Symptoms may continue afterward. If surgery, medication or hormonal contraception makes that timeline unclear, explain that history to your clinician.
You may be looking for relief now, weighing whether to start treatment years later, or wondering whether a previous plan still fits. Those are different decisions. Bring the timeline and your current priorities into the same conversation.
What could hormone therapy help with after menopause?
Systemic hormone therapy can reduce bothersome hot flashes and night sweats. Better control of night sweats may help when they interrupt sleep. These are general HRT benefits, not established outcomes for Estrada's specific compounded formulation.
If vaginal dryness or painful sex is the main concern, a local treatment may be more appropriate. A cream applied vaginally is not automatically a low-dose local therapy; Estrada is intended for systemic use. Match the treatment to the symptom rather than choosing on application route alone.
When you start matters. So does your history.
For many healthy people with bothersome symptoms, the balance of systemic HRT benefits and risks is more favorable before age 60 or within 10 years of menopause. This is a guide for assessment, not an automatic approval or a universal cutoff.
Tell your clinician when your periods ended, whether you have used hormones before and whether you have a uterus. Previous cancers, blood clots, stroke, heart or liver disease, and unexplained bleeding can change what is appropriate. Serious HRT risks include blood clots, stroke and certain cancers.
Sources[3]
Understand what choosing Estrada would mean
Estrada combines bioidentical estradiol and progesterone in a compounded prescription vaginal cream. It is not FDA-approved. FDA does not evaluate compounded drugs for safety, effectiveness or quality before marketing, and ACOG recommends suitable FDA-approved menopausal hormone therapies over compounded options.
Ask your OB/GYN why a compounded option is being considered, what approved or nonhormonal alternatives fit, and how follow-up would work. If you have a uterus, ask how your prescribed regimen protects its lining. An ingredient list alone cannot establish adequate protection for a particular dose and route.
Bleeding after menopause deserves its own assessment
Contact a clinician about vaginal bleeding after menopause, even if it is light or happens only once. Many causes are treatable, but bleeding can also signal a serious condition. Do not assume it is simply hormones changing again.
If you use HRT, tell your prescriber about bleeding and when it started. Its significance depends on your treatment and history; this guide cannot determine whether it is expected.
Sources[7]
An OB/GYN for the decision—and the questions afterward
Soha starts with a questionnaire reviewed by an OB/GYN. A phone or video conversation can be arranged when needed. If Estrada is appropriate and prescribed, it ships to your home.
During an active subscription, unlimited messaging lets you raise questions with your OB/GYN about your experience. Messages can be sent at any time, without a guaranteed reply time. This is not emergency care.
Before starting, understand what you are treating, how to use your prescription and how the plan will be reviewed. Your follow-up should consider whether the treatment still fits you, not just whether you need another shipment.
Questions you may still have
Is Estrada only for people whose periods have stopped?
No. Soha evaluates people seeking care during both perimenopause and menopause. This guide focuses on the questions that matter after menopause; your OB/GYN determines whether Estrada is appropriate for you.
Sources[4]
Is it too late to ask about HRT several years after menopause?
You can ask for an assessment. Starting later requires careful consideration of age, time since menopause and medical history. It is not the same decision as continuing a treatment you already use.
Sources[2]
Do I need systemic HRT if vaginal dryness is my only symptom?
Does menopause mean I should stay on Estrada indefinitely?
No automatic duration applies to everyone. Review your symptoms, benefits, risks and preferences with your clinician over time. A subscription does not replace that treatment decision.
Sources[2]
Sources and further reading
These sources explain the general medical information in this guide. They are not endorsements of Soha or evidence of outcomes with Estrada.
- Office on Women's Health: Menopause basics
- NHS: When to take HRT — stage and timing considerations
- The Menopause Society: Hormone Therapy — general benefits and risks
- Soha: Estrada and care information — company source
- ACOG: Compounded Bioidentical Menopausal Hormone Therapy
- FDA: Understanding the Risks of Compounded Drugs
- NHS: Postmenopausal bleeding
Make your care about how you want to live now.
Start with the symptoms that are getting in your way. Learn how Soha's OB/GYN assessment and ongoing support work after menopause.
Meet your menopause care options
